3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenylether
|
- $237 - $720
- Product name: 3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenylether
- CAS: 1219961-34-8
- MF: C18H21NO
- MW: 267.37
- EINECS:
- MDL Number:MFCD13559961
- Synonyms:3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenylether;3-(4-(2-PHENYLPROPAN-2-YL)PHENOXY)AZETIDINE;Azetidine, 3-[4-(1-methyl-1-phenylethyl)phenoxy]-
4 prices
Selected condition：
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 2.500g
- 5g
- ManufacturerChemenu
- Product numberCM300529
- Product description3-(4-(2-Phenylpropan-2-yl)phenoxy)azetidine 95%
- Packaging5g
- Price$421
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11326537
- Product description3-(4-(2-Phenylpropan-2-yl)phenoxy)azetidine 95+%
- Packaging5g
- Price$446
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number049541
- Product description3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenylether
- Packaging500mg
- Price$237
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number049541
- Product description3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenylether
- Packaging2.500g
- Price$720
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM300529 | 3-(4-(2-Phenylpropan-2-yl)phenoxy)azetidine 95% | 5g | $421 | 2021-12-16 | Buy |
| Crysdot | CD11326537 | 3-(4-(2-Phenylpropan-2-yl)phenoxy)azetidine 95+% | 5g | $446 | 2021-12-16 | Buy |
| Matrix Scientific | 049541 | 3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenylether | 500mg | $237 | 2021-12-16 | Buy |
| Matrix Scientific | 049541 | 3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenylether | 2.500g | $720 | 2021-12-16 | Buy |
Properties
Boiling point :393.0±42.0 °C(Predicted)
Density :1.070±0.06 g/cm3(Predicted)
pka :9.48±0.40(Predicted)
Density :1.070±0.06 g/cm3(Predicted)
pka :9.48±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|